Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine versus risperidone in schizophrenia with predominant negative symptoms
2012-005485-36Phase 3Completed
- Sponsor
- Gedeon Richter Plc
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cariprazine in schizophrenia, sponsored by Gedeon Richter Plc. Started Feb 2013; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2012-005485-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005485-36.